NCT02783846View on ClinicalTrials.gov

The Effects of Different Doses of Dexmedetomidine on Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index: a Double-blinded, Placebo-controlled Trial

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Loss of Consciousness
Interventions
OTHER

normal saline

receive equal volume of normal saline

DRUG

dexmedetomidine 0.5 µg/kg

receive dexmedetomidine 0.5 µg/kg

DRUG

dexmedetomidine 1.0 µg/kg

receive dexmedetomidine 1.0 µg/kg

All Listed Sponsors
lead

General Hospital of Ningxia Medical University

OTHER

NCT02783846 - The Effects of Different Doses of Dexmedetomidine on Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index: a Double-blinded, Placebo-controlled Trial | Biotech Hunter | Biotech Hunter